Search

Your search keyword '"McConville MJ"' showing total 360 results

Search Constraints

Start Over You searched for: Author "McConville MJ" Remove constraint Author: "McConville MJ"
360 results on '"McConville MJ"'

Search Results

301. Evidence that free GPI glycolipids are essential for growth of Leishmania mexicana.

302. Characterization of a novel GDP-mannose:Serine-protein mannose-1-phosphotransferase from Leishmania mexicana.

303. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells.

304. The glycoinositolphospholipids from Leishmania panamensis contain unusual glycan and lipid moieties.

305. Delineation of three pathways of glycosylphosphatidylinositol biosynthesis in Leishmania mexicana. Precursors from different pathways are assembled on distinct pools of phosphatidylinositol and undergo fatty acid remodeling.

306. Developmentally regulated changes in the cell surface architecture of Leishmania parasites.

307. The variant-specific surface protein of Giardia, VSP4A1, is a glycosylated and palmitoylated protein.

309. Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway.

310. Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction.

311. Structural studies on a lipoarabinogalactan of Crithidia fasciculata.

312. The surface glycoconjugates of parasitic protozoa: potential targets for new drugs.

313. Structure of Leishmania lipophosphoglycan: inter- and intra-specific polymorphism in Old World species.

314. Biosynthesis of the glycolipid anchor of lipophosphoglycan and the structurally related glycoinositolphospholipids from Leishmania major.

315. Stage-specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan.

316. Purification, partial characterization and immunolocalization of a proteophosphoglycan secreted by Leishmania mexicana amastigotes.

317. Glycoinositol-phospholipid profiles of four serotypically distinct Old World Leishmania strains.

318. O- and N-glycosylation of the Leishmania mexicana-secreted acid phosphatase. Characterization of a new class of phosphoserine-linked glycans.

319. Surface antigens of Leishmania mexicana amastigotes: characterization of glycoinositol phospholipids and a macrophage-derived glycosphingolipid.

320. Recognition of the major cell surface glycoconjugates of Leishmania parasites by the human serum mannan-binding protein.

321. Characterization of GDP-alpha-D-arabinopyranose, the precursor of D-Arap in Leishmania major lipophosphoglycan.

322. The developmental regulation and biosynthesis of GPI-related structures in Leishmania parasites.

323. Characterization of phosphoglycan-containing secretory products of Leishmania.

324. Glycosyl-phosphatidylinositol molecules of the parasite and the host.

325. Structures of glycosylphosphatidylinositol membrane anchors from Saccharomyces cerevisiae.

326. Characterization of glycoinositol phospholipids in the amastigote stage of the protozoan parasite Leishmania major.

327. The structure of Leishmania major amastigote lipophosphoglycan.

330. The glycoinositol phospholipids of Leishmania mexicana promastigotes. Evidence for the presence of three distinct pathways of glycolipid biosynthesis.

331. A simple purification of procyclic acidic repetitive protein and demonstration of a sialylated glycosyl-phosphatidylinositol membrane anchor.

332. Analysis of the neutral glycan fractions of glycosyl-phosphatidylinositols by thin-layer chromatography.

333. Identification of truncated forms of lipophosphoglycan in mutant cloned lines of Leishmania major that are deficient in mature lipophosphoglycan.

334. Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stage.

335. Stage-specific adhesion of Leishmania promastigotes to the sandfly midgut.

336. Refined structure of the lipophosphoglycan of Leishmania donovani.

337. Structure of Leishmania mexicana lipophosphoglycan.

338. Purification and characterization of an extracellular phosphoglycan from Leishmania donovani.

339. Identification of the defect in lipophosphoglycan biosynthesis in a non-pathogenic strain of Leishmania major.

340. Evolutionary aspects of GPI metabolism in kinetoplastid parasites.

341. Glycosylated-phosphatidylinositols as virulence factors in Leishmania.

342. Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani. Characterization of the promastigote and amastigote glycolipids.

343. Structure of the lipophosphoglycan from Leishmania major.

344. Structure of the glycosyl-phosphatidylinositol membrane anchor of the Leishmania major promastigote surface protease.

345. Structures of the glycoinositolphospholipids from Leishmania major. A family of novel galactofuranose-containing glycolipids.

346. Lipophosphoglycan expression and virulence in ricin-resistant variants of Leishmania major.

347. The glycoinositolphospholipid profiles of two Leishmania major strains that differ in lipophosphoglycan expression.

348. Carbohydrate antigens as possible parasite vaccines A case for the Leishmania glycolipid.

349. Immunochemical characterization of a glyco-inositol-phospholipid membrane antigen of Leishmania major.

350. Lipophosphoglycan of Leishmania major that vaccinates against cutaneous leishmaniasis contains an alkylglycerophosphoinositol lipid anchor.

Catalog

Books, media, physical & digital resources